Investment Rating - The report assigns a rating of "Buy" to Jiangnan New Materials with a target price of 132.00 CNY [5]. Core Viewpoints - Jiangnan New Materials is a leading player in copper-based new materials, focusing on the research, production, and sales of products such as copper balls, copper oxide powder, and high-precision copper-based heat sinks [2][15]. - The company has shown robust revenue and net profit growth, with projected revenues of 10.31 billion CNY, 12.44 billion CNY, and 14.82 billion CNY for 2025, 2026, and 2027 respectively, and net profits of 325 million CNY, 481 million CNY, and 689 million CNY for the same years [4][11]. - Jiangnan New Materials has a clear and stable shareholding structure, with the chairman holding 39.06% of the shares, ensuring effective governance [21][23]. Financial Summary - Total revenue is expected to grow from 6.82 billion CNY in 2023 to 14.82 billion CNY in 2027, reflecting a compound annual growth rate (CAGR) of approximately 19.1% [4]. - Net profit attributable to shareholders is projected to increase significantly from 142 million CNY in 2023 to 689 million CNY in 2027, indicating a strong growth trajectory [4]. - The earnings per share (EPS) is forecasted to rise from 0.97 CNY in 2023 to 4.72 CNY in 2027 [4]. Industry Overview - The copper-based new materials industry is experiencing significant growth, driven by increasing demand in sectors such as PCB manufacturing and liquid cooling systems [2][15]. - The global liquid cooling system market has been growing rapidly, with expectations of doubling in size by 2030 [2][15]. - Jiangnan New Materials' products, particularly copper oxide powder, are positioned to meet the high-end requirements of PCB manufacturing and other applications, enhancing their competitive edge [2][15]. Company Development - Jiangnan New Materials has been recognized as a top enterprise in the electronic circuit industry and has received numerous awards for its innovation and quality [16][17]. - The company has a strong focus on R&D, with 96 patents granted, and aims to enhance its product offerings continuously [16][28]. - The company plans to invest in a new project to produce 12,000 tons of electronic-grade copper oxide powder, which will significantly expand its production capacity and meet growing market demands [31][34].

Investment Rating - The report maintains a "Buy" rating for the company [5][2] Core Insights - The company has lowered its 2025 profit forecast but raised the profit forecasts and target price for 2026-2027, indicating a long-term positive development trend despite slightly lower-than-expected performance for 2025 [2][11] - The company is expected to achieve a revenue of 21.29 billion yuan and a net profit of 3.415 billion yuan for 2025, with significant growth anticipated in subsequent years [11][12] Financial Summary - Total revenue is projected to grow from 755 million yuan in 2023 to 2.128 billion yuan in 2025, representing a 98% increase [4] - Net profit (attributable to the parent company) is expected to rise from a loss of 48 million yuan in 2023 to a profit of 342 million yuan in 2025, reflecting a 426.8% increase [4] - Earnings per share (EPS) is forecasted to increase from -0.11 yuan in 2023 to 0.76 yuan in 2025 [4] - The return on equity (ROE) is expected to improve from -4.2% in 2023 to 17.0% in 2025 [4] Market Data - The company's target price has been raised to 115.05 yuan, up from a previous target of 75.20 yuan [11] - The stock has a market capitalization of 41.538 billion yuan and a price-to-earnings (P/E) ratio of 639.70 for 2024, decreasing to 121.43 for 2025 and 51.99 for 2026 [6][13] Business Outlook - The company is expected to benefit from rapid growth in the data communication market driven by artificial intelligence, with various product lines showing strong order growth compared to the previous year [11] - Key products such as AWG and MPO are anticipated to see significant demand increases, particularly in North America [11]

众生药业 002317.SZ 公司研究 | 首次报告 | 中药基本盘稳健，创新管线步入收获期 | | --- | 众生药业首次覆盖报告 核心观点 盈利预测与投资建议 ⚫ 我们看好公司中药化药双轮驱动，中药业务基本盘集采影响逐渐出清，化药创新药 临床管线步入后期，具备大品种和出海潜力，预计公司 2025-2027 年归母净利润分 别为 2.9/3.5/4.1 亿元，对应 EPS 分别为 0.34、0.41、0.48 元。我们采用 PE 估值， 参考行业平均市盈率，给予公司 2026 年 57 倍 PE，对应目标价 23.37 元，首次覆盖 给予"买入"评级。 风险提示 ⚫ 研发进展不及预期风险，市场竞争加剧风险，医药政策变化风险，中药材价格成本 上升风险。 ⚫ 。 公司主要财务信息 ⚫ 中药化药双轮驱动，加强业绩考核和创新药研发激励。公司以特色中成药为基础、 高端仿制药为依托、创新药为引领，具备多层次研发体系。近年来，营收保持稳 健，2024 年受资产减值损失计提影响，利润端亏损。2025 年前三季度，公司归母 净利润 2.5 亿元，同比增长 68.4%，已有所恢复。公司 2024 年推出员工持股计划， 给予核 ...

PCB 铜基新材料龙头，液冷助力发展提速 江南新材(603124) 江南新材深度研究 | [姓名table_Authors] | 电话 | 邮箱 | 登记编号 | | --- | --- | --- | --- | | 余伟民(分析师) | 010-50949926 | yuweimin@gtht.com | S0880525040028 | | 王彦龙(分析师) | 010-83939775 | wangyanlong@gtht.com | S0880519100003 | | 舒迪(分析师) | 021-38676666 | shudi@gtht.com | S0880521070002 | | 吴小沛(研究助理) | 021-23187269 | wuxiaopei@gtht.com | S0880125042240 | 本报告导读： 铜基新材料龙头，产品包括铜球、氧化铜粉及高精密铜基散热片，上游铜材行业， 下游主要应用于 PCB。 投资要点： | [Table_Finance] 财务摘要(百万元) | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | -- ...

[Table_scodeMsg1] 公司研究丨深度报告丨宁德时代（300750.SZ） [Table_Title] 迈向应用创新，再造宁德时代——换电篇 %% %% %% %% research.95579.com 1 丨证券研究报告丨 报告要点 [Table_Summary] 从宁德时代近两年的战略方向看，动力、储能电池持续的材料体系研发、极限制造创新仍是重 点和基础，与之同时面向市场应用的集成产品、商业模式创新有被更多的提及。因此，我们将 宁德时代的研究重点，从锂电池制造转向应用创新布局，关注换电与车电分离、滑板底盘、数 据中心储能集成、零碳电网等业务进展。本篇报告将重点介绍宁德时代的换电战略。 分析师及联系人 [Table_Author] SAC：S0490514040001 SAC：S0490522030001 SAC：S0490520090003 SFC：BQK482 请阅读最后评级说明和重要声明 2 / 22 %% %% %% %% research.95579.com 2 邬博华 曹海花 叶之楠 [Table_scodeMsg2] 宁德时代（300750.SZ） cjzqdt11111 [Tab ...

[Table_scodeMsg1] 公司研究丨深度报告丨千禾味业（603027.SH） [Table_Title] 千禾味业深度报告：大千世界，禾谷丰登 %% %% %% %% research.95579.com 1 丨证券研究报告丨 报告要点 [Table_Summary] 千禾味业经营周期改善，库存回归良性，2026 年有望重回增长。2025 年公司历经舆情影响， 整体处于修复调整期（也致短期内广宣、促销等投放增加），在 2025 年 9 月对 0 系列酱油焕新 升级，公司再次引领行业在清洁标签方面的积极转型。随着渠道库存去化基本完成，产品换代 梳理完毕，叠加线上渠道的修复，2026 年有望重回良性增长轨道。 分析师及联系人 [Table_Author] 董思远 徐爽 SAC：S0490517070016 SAC：S0490520030001 SFC：BQK487 请阅读最后评级说明和重要声明 2/27 %% %% %% %% research.95579.com 2 酱油行业进入成熟发展阶段，找寻结构性机会。行业升级聚焦"健康"（0 添加、减盐、有机） 与"功能"两大方向。基于日本经验，老龄化、家庭小 ...

股票研究 /[Table_Date] 2026.01.31 整体略低预期，长期发展趋势向好 仕佳光子(688313) ——2025 业绩预告点评 | [姓名table_Authors] | 电话 | 邮箱 | 登记编号 | | --- | --- | --- | --- | | 余伟民(分析师) | 010-50949926 | yuweimin@gtht.com | S0880525040028 | | 王彦龙(分析师) | 010-83939775 | wangyanlong@gtht.com | S0880519100003 | | 黎明聪(分析师) | 0755-23976500 | limingcong@gtht.com | S0880523080008 | | 桂海晟(研究助理) | 021-38031384 | guihaisheng@gtht.com | S0880124070058 | 本报告导读： 下调 2025 年盈利预测，上调 2026-2027 年盈利预测及目标价，维持增持 评级。业绩略低预期，长期发展趋势向好，业务 26 年增长可期。 投资要点： | [Table_Finance] ...

Email：duchong@zts.com.cn | 基本状况 | | | --- | --- | | 总股本(百万股) | 2,693.26 | | 流通股本(百万股) | 2,693.26 | | 市价(元) | 12.56 | | 市值(百万元) | 33,827.33 | | 流通市值(百万元) | 33,827.33 | 煤炭开采 执业证书编号：S0740522040001 1、《以量补价主业成长可期，提高分 红比例价值凸显》2025-03-28 淮北矿业（600985.SH） 证券研究报告/公司深度报告 2026 年 01 月 30 日 | 买入（维持） 评级： | | 公司盈利预测及估值 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 指标 | | 2023A | 2024A | 2025E | 2026E | 2027E | | 分析师：杜冲 | | 营业收入（百万元） | | 73,387 | 65,735 | 42,981 | 47,728 | 50,809 | | | | 增长率 yo ...

证券研究报告|公司点评报告 [Table_Date] 2026 年 01 月 30 日 [Table_Title] 业绩超预期，期待 26 年加速开店 [Table_Title2] 三夫户外(002780) | [Table_DataInfo] 评级： | 增持 | 股票代码： | 002780 | | --- | --- | --- | --- | | 上次评级： | 增持 | 52 周最高价/最低价： | 19.2/8.74 | | 目标价格： | | 总市值(亿) | 24.67 | | 最新收盘价： | 14.92 | 自由流通市值(亿) | 19.49 | | | | 自由流通股数(百万) | 130.65 | [Table_Summary] 事件概述 公司发布 2025 业绩预告，归母净利为 4500-6750 万元，同比增长 309-414%，预告中枢净利超市场预期。 分析判断: 我们分析，X 品牌营收持续增长、我们预计超预期主要来自松鼠乐园减亏，我们此前预计亏损 2000 万，上 半年为亏损 420 万元，减亏明显，全年我们预计亏损为几百万元。 投资建议 我们分析，展望 26 年，（1）X 品 ...

公司是国内首批从事光纤激光切割控制系统开发的企业，技术积累扎实，核心业务 稳健发展，大客户基础扎实，智能化精密化高端业务发展前景广阔，积极布局工业 人工智能等新兴领域，具备穿越行业波动的长期盈利能力。 投资要点： | [Table_Finance] 财务摘要(百万元) | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入 | 1,407 | 1,735 | 2,145 | 2,736 | 3,692 | | (+/-)% | 56.6% | 23.3% | 23.6% | 27.5% | 34.9% | | 净利润(归母) | 729 | 883 | 1,085 | 1,308 | 1,674 | | (+/-)% | 52.0% | 21.1% | 22.9% | 20.5% | 28.0% | | 每股净收益(元) | 2.52 | 3.06 | 3.76 | 4.53 | 5.80 | | 净资产收益率(%) | 14.7% | 16.1% | 16.5% | 18.2% | 21. ...